PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $135,000 | -79.2% | 40,634 | -69.1% | 0.00% | -80.0% |
| Q4 2015 | $650,000 | -1.8% | 131,316 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $662,000 | -16.9% | 131,316 | +4.2% | 0.02% | -6.2% |
| Q2 2015 | $797,000 | -14.3% | 125,985 | -4.7% | 0.02% | -33.3% |
| Q1 2015 | $930,000 | -6.5% | 132,145 | +2.3% | 0.02% | -7.7% |
| Q4 2014 | $995,000 | +1.2% | 129,218 | -1.9% | 0.03% | +23.8% |
| Q3 2014 | $983,000 | -17.0% | 131,726 | +7.8% | 0.02% | -19.2% |
| Q2 2014 | $1,184,000 | +22.1% | 122,229 | +4.6% | 0.03% | +18.2% |
| Q1 2014 | $970,000 | +14.0% | 116,840 | +15.9% | 0.02% | +10.0% |
| Q4 2013 | $851,000 | +17.1% | 100,849 | +10.7% | 0.02% | +5.3% |
| Q3 2013 | $727,000 | +40.3% | 91,129 | +35.6% | 0.02% | -5.0% |
| Q2 2013 | $518,000 | – | 67,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |